Related Experiment Video
Updated: Feb 6, 2026

Tobacco Hornworm as an Insect Model System for Cannabinoid Pre-clinical Studies
Published on: December 29, 2021
Considerations for clinical trials to study cannabinoids in Canadian children with neurologic disorders
1Department of Pediatrics and Child Health (Kelly), Rady College of Medicine, University of Manitoba, Winnipeg, Man.; Clinical Trials Platform (Kelly), George and Fay Yee Centre for Healthcare Innovation, Winnipeg, Man.; Division of Allergy and Immunology (Junker), British Columbia Children's Hospital, Vancouver, BC; Department of Pediatrics, Faculty of Medicine (Junker), University of British Columbia, Vancouver, BC Lauren.Kelly@umanitoba.ca.
No abstract available in PubMed .
More Related Videos
06:12Recording Horizontal Saccade Performances Accurately in Neurological Patients Using Electro-oculogram
Published on: March 13, 2018
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Design Consideration
The factor of safety is another key...
Trial and Error and Algorithm
Aneurysm II: Clinical Manifestations and Diagnostic Studies